Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02156739 · ClinicalTrials.gov registry record · NA
Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions
A NA study of Hepatocellular Carcinoma and Metastatic Malignant Neoplasm in the Liver, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT02156739: Active NA study of Hepatocellular Carcinoma and Metastatic Malignant Neoplasm in the Liver, sponsored by M.D. Anderson Cancer Center.
NCT02156739 is a NA study of Hepatocellular Carcinoma and Metastatic Malignant Neoplasm in the Liver that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 100 participants, below the 257-participant average among 145 other Hepatocellular Carcinoma trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02156739, a NA study of Hepatocellular Carcinoma and Metastatic Malignant Neoplasm in the Liver, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial studies contrast-enhanced magnetic resonance imaging (MRI) in detecting nonmalignant and malignant liver lesions. Diagnostic procedures, such as MRI, may help find and diagnose nonmalignant and malignant liver lesions. Contrast agents, such as gadoxetate disodium and gadobutrol, may help doctors to see MRI images more clearly.
Primary Outcome
Summary statistics of sensitivity, specificity, true positives, true negatives, false positives, and false negatives will be provided for gadoxetate disodium and gadoxetate disodium + gadobutrol method. Accuracy, sensitivity, specificity, positive predictive value, and negative predictive value will be estimated along with corresponding 95% confidence intervals for the two methods. Comparison between the two methods will be made following method by Obuchowski. Other statistical analyses will be
Conditions Studied
Interventions
- PROCEDURE Contrast-enhanced Magnetic Resonance Imaging
- DRUG Gadobutrol
- DRUG Gadoxetate Disodium
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2014-10-13 |
| Est. Completion | 2026-06-01 |
| Phase | NA |
What the registry record for NCT02156739 still lists
NCT02156739 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 257-participant average among 145 other Hepatocellular Carcinoma trials with a reported enrollment target (61% lower).
The record links to 4 conditions, with Hepatocellular Carcinoma appearing as the primary indexed condition, and to 3 interventions - of which Contrast-enhanced Magnetic Resonance Imaging is the first listed.
NCT02156739 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02156739 about?
NCT02156739 is a clinical study titled "Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions". This clinical trial studies contrast-enhanced magnetic resonance imaging (MRI) in detecting nonmalignant and malignant liver lesions. Diagnostic procedures, such as MRI, may help find and diagnose nonmalignant and malignant liver lesions. Contrast agents, such as gadoxetate disodium and gadobutrol, ...
What is the current status of trial NCT02156739?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2014-10-13. Estimated completion is 2026-06-01.
What conditions does trial NCT02156739 study?
This clinical trial studies the following conditions: Hepatocellular Carcinoma, Metastatic Malignant Neoplasm in the Liver, Liver and Intrahepatic Bile Duct Disorder, Primary Malignant Liver Neoplasm.
What interventions are being tested in trial NCT02156739?
The interventions under investigation include: Contrast-enhanced Magnetic Resonance Imaging (PROCEDURE), Gadobutrol (DRUG), Gadoxetate Disodium (DRUG).
Who is sponsoring clinical trial NCT02156739?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02156739 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatocellular Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02156739's enrollment target sits among peer trials
100 59th of 145 higher than 82 of 145 other Hepatocellular Carcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hepatocellular Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Targeted Navigation in Hepatocellular Carcinoma (HCC)
RECRUITING · NA
-
Y90 Radioembolization Dose Delivery and Radiation Exposure Assessment
RECRUITING · NA
-
HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer
RECRUITING · NA
-
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
RECRUITING · NA
-
Psychoeducational Intervention for Patients With Hepatocellular Carcinoma
RECRUITING · NA
-
CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI